These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1968975

  • 1. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
    Damase-Michel C, Montastruc JL, Gharib C, Geelen G, De Saint-Blanquat G, Tran MA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
    [Abstract] [Full Text] [Related]

  • 2. Effect of the dopamine D2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
    Szabo B, Crass D, Starke K.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):806-15. PubMed ID: 1359118
    [Abstract] [Full Text] [Related]

  • 3. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S, Ann HS, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [Abstract] [Full Text] [Related]

  • 4. Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate/NaCl hypertensive rats is related to atrial natriuretic peptide release.
    Chen YF, Jin HK, Paul R, Nagahama S.
    J Pharmacol Exp Ther; 1988 Aug; 246(2):485-92. PubMed ID: 2969976
    [Abstract] [Full Text] [Related]

  • 5. Effects of dopaminergic drugs on the sympathoadrenal system.
    Damase-Michel C, Montastruc JL, Tran MA.
    Hypertens Res; 1995 Jun; 18 Suppl 1():S119-24. PubMed ID: 8529040
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [Abstract] [Full Text] [Related]

  • 7. Modulation of adrenal catecholamine release by DA2 dopamine receptors in the anaesthetized dog.
    Foucart S, Lacaille-Belanger P, Kimura T, Nadeau R, de Champlain J.
    Clin Exp Pharmacol Physiol; 1988 Aug; 15(8):601-11. PubMed ID: 2908435
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I, Lorrain J, Di Paola ED, Lhoste F, Payen B, Dennis T, Scatton B.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat.
    Nagahama S, Chen YF, Lindheimer MD, Oparil S.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):426-32. PubMed ID: 3772802
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I, Lefevre-Borg F, Lhoste F, Sabatier C, Richer C, Giudicelli JF.
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [Abstract] [Full Text] [Related]

  • 11. Is adrenal medulla involved in the antihypertensive effect of nicardipine?
    Tran MA, De Saint-Blanquat G, Valet P, Tran LD, Anglade F, Gaillard G, Rascol O, Brisac AM, Montastruc JL, Montastruc P.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1116-20. PubMed ID: 3252026
    [Abstract] [Full Text] [Related]

  • 12. Prolonged central effects of quinpirole on cardiovascular regulation.
    van den Buuse M, Morton SJ, Cornish JL, Head GA.
    J Pharmacol Exp Ther; 1996 Apr; 277(1):473-83. PubMed ID: 8613956
    [Abstract] [Full Text] [Related]

  • 13. Involvement of vasopressin in the cardiovascular effects of quinpirole.
    Damase-Michel C, Montastruc JL, Tran MA, Gharib C, Geelen G, Montastruc P.
    Eur J Pharmacol; 1990 Aug 02; 184(1):179-83. PubMed ID: 1976526
    [Abstract] [Full Text] [Related]

  • 14. Studies on the cardiovascular actions of apomorphine in dogs: central versus peripheral mechanisms and role of the adrenal medulla.
    Montastruc JL, Guiol C, Tran MA, Lhoste F, Montastruc P.
    Arch Int Pharmacodyn Ther; 1985 Sep 02; 277(1):92-103. PubMed ID: 4062436
    [Abstract] [Full Text] [Related]

  • 15. Central effects of quinpirole on blood pressure of spontaneously hypertensive rats.
    van den Buuse M.
    J Pharmacol Exp Ther; 1992 Jul 02; 262(1):303-11. PubMed ID: 1352551
    [Abstract] [Full Text] [Related]

  • 16. [Experimental study of the hypotensive effect of apomorphine].
    Montastruc JL, Guiol C.
    Arch Mal Coeur Vaiss; 1984 Oct 02; 77(11):1176-80. PubMed ID: 6441536
    [Abstract] [Full Text] [Related]

  • 17. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF, Steenberg ML.
    J Pharmacol Exp Ther; 1984 Jan 02; 228(1):161-7. PubMed ID: 6694099
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Jan 02; 236(1):65-70. PubMed ID: 2867216
    [Abstract] [Full Text] [Related]

  • 19. Neuronal and postjunctional components in the blood pressure effects of dopamine and bromocriptine in rabbits.
    Ensinger H, Majewski H, Hedler L, Starke K.
    J Pharmacol Exp Ther; 1985 Sep 02; 234(3):681-90. PubMed ID: 2993590
    [Abstract] [Full Text] [Related]

  • 20. Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist.
    Hahn RA, MacDonald BR.
    J Pharmacol Exp Ther; 1984 Sep 02; 230(3):558-68. PubMed ID: 6470973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.